Selective NRF2 target induction despite falling NFE2L2 transcription across the MASLD spectrum: implications for marginal donor grafts and KEAP1-targeted therapy.
- DOI
- 10.1016/j.freeradbiomed.2026.10.038
- Published
- 2026 Dec 2
- Container
- Free radical biology & medicine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.freeradbiomed.2026.10.038,
title = {Selective NRF2 target induction despite falling NFE2L2 transcription across the MASLD spectrum: implications for marginal donor grafts and KEAP1-targeted therapy.},
author = {Campbell S and O'Reilly R and Ahmed O and McElheron M and Chapman WC and O'Farrelly C},
year = {2026},
journal = {Free radical biology \& medicine},
doi = {10.1016/j.freeradbiomed.2026.10.038},
url = {https://doi.org/10.1016/j.freeradbiomed.2026.10.038}
}RIS
TY - JOUR TI - Selective NRF2 target induction despite falling NFE2L2 transcription across the MASLD spectrum: implications for marginal donor grafts and KEAP1-targeted therapy. AU - Campbell S AU - O'Reilly R AU - Ahmed O AU - McElheron M AU - Chapman WC AU - O'Farrelly C PY - 2026 JO - Free radical biology & medicine DO - 10.1016/j.freeradbiomed.2026.10.038 UR - https://doi.org/10.1016/j.freeradbiomed.2026.10.038 ER -
APA
S, C., R, O., O, A., M, M., WC, C., & C, O. (2026). Selective NRF2 target induction despite falling NFE2L2 transcription across the MASLD spectrum: implications for marginal donor grafts and KEAP1-targeted therapy.. Free radical biology & medicine. https://doi.org/10.1016/j.freeradbiomed.2026.10.038
Source records
- pubmed · retrieved 2026-11-10T20:35:28.119Z